Company news

Hanchorbio Inc. (TWSE:7827) news

Hanchorbio Inc. news releases on 6ix. Latest, Sep 9, 2026: HanchorBio Reaches Clinical Milestone for HCB101 as US FDA Allows Continued Treatment for Phase 1…

View Hanchorbio Inc. →

Press releases & updates

HanchorBio Reaches Clinical Milestone for HCB101 as US FDA Allows Continued Treatment for Phase 1 Patient Experiencing Clinical Benefit

September 9, 2026

HanchorBio Tests Broader Ambitions for HCB101 Through InxMed Partnership

July 8, 2026